Ximelagatran, melagatran dosage in severe renal impairment

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1400, 2003-01, pp. : 17-17

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Influence of Severe Renal Impairment on the Pharmacokinetics and Pharmacodynamics of Oral Ximelagatran and Subcutaneous Melagatran

By Eriksson U.G.

Clinical Pharmacokinetics, Vol. 42, Iss. 8, 2003-01 ,pp. : 743-753

Adis International

Access to resources Recommend Favorite

Ximelagatran + melagatran superior against VTE

Inpharma, Vol. 1, Iss. 1364, 2002-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Adjust valganciclovir dosage in renal impairment

Inpharma, Vol. 1, Iss. 1359, 2002-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

Drug dosage in renal impairment: variation in recommendations

Inpharma, Vol. 1, Iss. 1490, 2005-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Ximelagatran/Melagatran: A Review of its Use in the Prevention of Venous Thromboembolism in Orthopaedic Surgery

By Evans H.C. Perry C.M. Faulds D.

Drugs, Vol. 64, Iss. 6, 2004-01 ,pp. : 649-678

Adis International

Access to resources Recommend Favorite